Sedation with Precedex can be continued safely for an extended period, so that sedation can be continued uninterrupted before, during and after mechanical ventilation. Clinically significant episodes of bradycardia, sinus arrest and hypotension have been associated with Precedex infusion and may necessitate medication intervention.
Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has approximately 13,500 employees. Learn more at www.hospira.com.
About Hospira Japan
Hospira has been operating in Japan since March 2006. Hospira Japan Co., Ltd. offers specialty acute-care and oncology pharmaceuticals, and infusion therapy and medication management solutions. Through these highly specialized products, Hospira Japan offers solutions to the problems and challenges that healthcare professionals face in their clinical practice. As a partner that the patients and healthcare professionals can trust in, Hospira Japan holds high aspirations and contributes to the realization of the ease and safety in medical care. The Japan office is located in Osaka, and has approximately 80 employees
|SOURCE Hospira, Inc.|
Copyright©2010 PR Newswire.
All rights reserved